The 13D Report
The 13D Report
Shareholder activism
⌘K
Signup free
activistletters

Servotronics (SVT) Faces Beaver Hollow Wellness’ Push for Director Change After Cash Collapse and Governance Failures

Summary

Beaver Hollow Wellness (May 13, 2025) launched its S.A.V.E. Servotronics Plan, urging board change after years of financial decline at Servotronics. It cites net income dropping from $5M in 2021 to a $0.3M loss in 2024, cash collapsing to just $46K, and failed debt and divestiture decisions that left the company lagging peers. BHW proposes new independent directors, lean manufacturing, debt restructuring, stronger governance, and workforce empowerment to restore profitability and credibility, urging shareholders to back its slate and withhold support from entrenched incumbents.

Company Name: Servotronics Inc
Symbol: SVT
Filing Date: May-13-2025
Filer Name: Beaver Hollow Wellness, LLC

Download Presentation
Beaver-Servotronics-May-13-2025.pdf
4 MB
download-circle

Source:

https://www.sec.gov/Archives/edgar/data/89140/000143774925016502/bhw20250513_dfan14a.htm

Member discussion

More like this

STAAR Surgical (STAA): Broadwood Partners Urges Shareholders to Reject Alcon Merger Over Governance and Valuation Concerns

Summary Broadwood Partners’ presentation argues that STAAR Surgical’s sale to Alcon is ill-timed, flawed, and undervalued. It claims STAAR’

Khrom Capital Pushes Acadia Healthcare (ACHC) Board to Pursue Sale, Slams Entrenched Leadership and Poor Capital Allocation

Summary Khrom Capital, owning 5.5% of Acadia Healthcare, criticized the company’s decade-long underperformance, poor capital allocation, and entrenched

STAAR Surgical (STAA): Broadwood Capital Urges Shareholders to Reject Alcon Merger, Highlighting Governance Conflicts and Poor Timing

Summary Broadwood Capital, owning 27.5% of STAAR Surgical, urged shareholders to vote against the proposed $28-per-share sale to Alcon,

Al Hartman Presses Silver Star Properties REIT (SLVS) Holders: Reject Current Board, Back Liquidation Plan Amid Alleged Misconduct and Value Destruction

Summary Al Hartman’s Hartman Shareholder Alliance urges Silver Star investors to vote the BLUE proxy as a “last chance”

Broadwood Partners Challenges STAAR Surgical (STAA) Sale to Alcon, Citing Inopportune Timing, Governance Issues, and Undervaluation

Summary Broadwood Partners, STAAR Surgical’s largest shareholder with a 27.5% stake, urged stockholders to vote against the proposed

Yunqi Capital Challenges STAAR Surgical (STAA)–Alcon Deal, Citing Undervaluation, Weak China Outlook Assumptions, and Governance Failures

Summary Yunqi Capital, a 5.1% shareholder of STAAR Surgical, announced it will vote against the company’s proposed $28